Randox Life Sciences Produce Highly Sensitive Antibodies to a Range of Drugs of Abuse Targets
Product News Jun 29, 2011
For 30 years Randox Life Sciences has developed and manufactured a wide range of products including high quality, cost effective recombinant proteins, polyclonal antibodies and conjugates targeting drugs of abuse, steroids, hormones and biochemical markers.
These specific life science products are manufactured at our ISO 13485 certified manufacturing plant in the United Kingdom using state of the art facilities.
It is now accepted that drug misuse is a large and growing problem affecting not only the user but society as a whole. Drug testing can provide a tool for detecting users and monitoring the compliance of subjects in recovery programs.
Randox Life Sciences has developed an extensive range of drug targeted antibodies for research and development applications.
Our high quality, cost effective antibodies and conjugates are specific to a range of Drugs of Abuse targets including Antidepressants, Barbiturates, Benzodiazepines, Hallucinogens, Opiates, Sedatives, Stimulants and Therapeutic Drugs.
Randox Life Sciences are continually developing antibodies to new Drugs of Abuse targets. We have recently released a range of drug targeted antibodies including Anti-Haloperidol, Anti-Methicathinone, Anti-Norfentanyl and therapeutic antibody Anti-Theophylline suitable for use in the development of in-house detection methods such as ELISA.
Our antibodies have corresponding HRP conjugates (tracers) available free for a limited time only with each order.